The shares of Facebook, Inc. (NASDAQ:FB) has been pegged with a rating of Buy by Guggenheim in its latest research note that was published on April 4th, 2019. The research company has also assigned a $200 price target. Guggenheim wasn’t the only research firm that published a report of Facebook, Inc., with other equities research analysts also giving their opinion on the stock. Needham advised investors in its research note published on March 18th, 2019, to Hold the FB stock. The stock had earned Buy rating from Nomura when it published its report on March 11th, 2019. That day the Nomura set price target on the stock to $215. The stock was given Neutral rating by UBS in its report released on January 31st, 2019, the day when the price target on the stock was placed at $170. Rosenblatt was of a view that FB is Buy in its latest report on January 31st, 2019 while giving it a price target of $212. RBC Capital Mkts thinks that FB is worth Outperform rating. This was contained in the firm’s report on January 31st, 2019 in which the stock’s price target was also moved to $200.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 7 believe it has the potential for further growth, thus rating it as Hold while 17 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $196.44. The price of the stock the last time has raised by 45.33% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 66.69.
The shares of the company dipped by -0.05% during the trading session on Wednesday, reaching a low of $178.36 while ending the day at $178.78. During the trading session, a total of 9.51 million shares were traded which represents a 48.63% incline from the average session volume which is 18.52M shares. FB had ended its last session trading at 178.87. Facebook, Inc. currently has a market cap of $511.11B, while its P/E ratio stands at 23.59, while its P/E earnings growth sits at 9.15, with a beta of 0.89. Facebook, Inc. debt-to-equity ratio currently stands at 0.00, while its quick ratio hovers at 7.20. FB 52-week low price stands at $123.02 while its 52-week high price is $218.62.
The company in its last quarterly report recorded $2.38 earnings per share which is above the $2.18 predicted by most analysts. The Facebook, Inc. generated $16,914.00 million in revenue during the last quarter, which is slightly higher than the $16,388.80 million predicted by analysts. In the second quarter last year, the firm recorded $1.76 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 26.05%. Facebook, Inc. has the potential to record 7.58 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Sandler O’Neill published a research note on March 19th, 2019 where it informed investors and clients that MetLife, Inc. (NYSE:MET) is now rated as Hold. Needham also rated MET as Downgrade on March 18th, 2019, with its price target of $74 suggesting that MET could surge by 9.73% from its current share price. Even though the stock has been trading at $46.19/share, analysts expect it to surge higher by -0.82% to reach $50.75/share. It started the day trading at $46.37 and traded between $45.51 and $45.81 throughout the trading session.
A look at its technical shows that MET’s 50-day SMA is 44.42 while its 200-day SMA stands at 44.32. The stock has a high of $48.92 for the year while the low is $37.76. The company’s P/E ratio currently sits at 9.28, while the P/B ratio is 0.85. At the moment, only of MetLife, Inc. shares were sold short. The company’s average trading volume currently stands at 5.69M shares, which means that the short-interest ratio is just 2.41 days. Over the past seven days, the company moved, with its shift of 2.19%. Looking further, the stock has raised 2.09% over the past 90 days while it gained 4.66% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more MET shares, increasing its portfolio by +1.89% during the last quarter. This move now sees The Vanguard Group Inc purchasing 1,229,037 shares in the last quarter, thus it now holds 66,196,593 shares of MET, with a total valuation of $2,817,988,964. Dodge Cox meanwhile sold more MET shares in the recently filed quarter, changing its stake to $1,964,259,959 worth of shares. SSgA Funds Management Inc followed the path by decreasing its MET portfolio by -4.01% in the quarter. This means that SSgA Funds Management Inc sold -1,922,933 shares in the last quarter and now controls 45,973,423 shares of the MET stock, with the valuation hitting $1,957,088,617.
Similarly, BlackRock Fund Advisors increased its MetLife, Inc. shares by +5.02% during the recently filed quarter. After buying 1,989,288 shares in the last quarter, the firm now controls 41,585,560 shares of MetLife, Inc. which are valued at $1,770,297,289. In the same vein, Wellington Management Co LLP decreased its MetLife, Inc. shares by during the most recent reported quarter. The firm sold -4,183,704 shares during the quarter which decreased its stakes to 40,158,721 shares and is now valued at $1,709,556,753. Following these latest developments, around 0.10% of MetLife, Inc. stocks are owned by institutional investors and hedge funds.